86 related articles for article (PubMed ID: 38511494)
1. Activities and binding partners of E3 ubiquitin ligase DTX3L and its roles in cancer.
Vela-Rodríguez C; Lehtiö L
Biochem Soc Trans; 2022 Dec; 50(6):1683-1692. PubMed ID: 36421918
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic overview of ADP-ribosylation reactions.
Sung VM
Biochimie; 2015 Jun; 113():35-46. PubMed ID: 25828806
[TBL] [Abstract][Full Text] [Related]
3. Oligomerization mediated by the D2 domain of DTX3L is critical for DTX3L-PARP9 reading function of mono-ADP-ribosylated androgen receptor.
Vela-Rodríguez C; Yang C; Alanen HI; Eki R; Abbas TA; Maksimainen MM; Glumoff T; Duman R; Wagner A; Paschal BM; Lehtiö L
Protein Sci; 2024 Apr; 33(4):e4945. PubMed ID: 38511494
[TBL] [Abstract][Full Text] [Related]
4. Oligomerisation mediated by the D2 domain of DTX3L is critical for DTX3L-PARP9 reading function of mono-ADP-ribosylated androgen receptor.
Vela-Rodríguez C; Yang C; Alanen HI; Eki R; Abbas TA; Maksimainen MM; Glumoff T; Duman R; Wagner A; Paschal BM; Lehtiö L
bioRxiv; 2023 Nov; ():. PubMed ID: 38076829
[TBL] [Abstract][Full Text] [Related]
5. Reconstitution of the DTX3L-PARP9 complex reveals determinants for high-affinity heterodimerization and multimeric assembly.
Ashok Y; Vela-Rodríguez C; Yang C; Alanen HI; Liu F; Paschal BM; Lehtiö L
Biochem J; 2022 Feb; 479(3):289-304. PubMed ID: 35037691
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin Modification by the E3 Ligase/ADP-Ribosyltransferase Dtx3L/Parp9.
Yang CS; Jividen K; Spencer A; Dworak N; Ni L; Oostdyk LT; Chatterjee M; Kuśmider B; Reon B; Parlak M; Gorbunova V; Abbas T; Jeffery E; Sherman NE; Paschal BM
Mol Cell; 2017 May; 66(4):503-516.e5. PubMed ID: 28525742
[TBL] [Abstract][Full Text] [Related]
7. Structural insights into ADP-ribosylation of ubiquitin by Deltex family E3 ubiquitin ligases.
Chatrin C; Gabrielsen M; Buetow L; Nakasone MA; Ahmed SF; Sumpton D; Sibbet GJ; Smith BO; Huang DT
Sci Adv; 2020 Sep; 6(38):. PubMed ID: 32948590
[TBL] [Abstract][Full Text] [Related]
8. Synthetic Dual Cysteine-ADP Ribosylated Peptides from the Androgen Receptor are Recognized by the DTX3L/PARP9 Complex.
Wijngaarden S; Yang C; Vela-Rodríguez C; Lehtiö L; Overkleeft HS; Paschal BM; Filippov DV
ACS Chem Biol; 2023 Nov; 18(11):2377-2384. PubMed ID: 37939374
[TBL] [Abstract][Full Text] [Related]
9. Updated protein domain annotation of the PARP protein family sheds new light on biological function.
Suskiewicz MJ; Munnur D; Strømland Ø; Yang JC; Easton LE; Chatrin C; Zhu K; Baretić D; Goffinont S; Schuller M; Wu WF; Elkins JM; Ahel D; Sanyal S; Neuhaus D; Ahel I
Nucleic Acids Res; 2023 Aug; 51(15):8217-8236. PubMed ID: 37326024
[TBL] [Abstract][Full Text] [Related]
10. CHIP inhibits odontoblast differentiation through promoting DLX3 polyubiquitylation and degradation.
Zheng H; Zhang X; Fu J; Xue Y; Chen Z; Yang G; Chen Y; Chen D; Yuan G
Development; 2023 May; 150(10):. PubMed ID: 37213079
[TBL] [Abstract][Full Text] [Related]
11. AIP4 regulates adipocyte differentiation by targeting C/EBPα for ubiquitin-mediated proteasomal degradation.
Chowdhury S; Singh AK; Srivastava S; Upadhyay V; Sethi A; Siddiqui S; Trivedi AK
J Cell Biochem; 2023 Jul; 124(7):961-973. PubMed ID: 37204112
[TBL] [Abstract][Full Text] [Related]
12. Fast and accurate protein structure search with Foldseek.
van Kempen M; Kim SS; Tumescheit C; Mirdita M; Lee J; Gilchrist CLM; Söding J; Steinegger M
Nat Biotechnol; 2024 Feb; 42(2):243-246. PubMed ID: 37156916
[TBL] [Abstract][Full Text] [Related]
13. The E3 ubiquitin ligase NEDD4-1 protects against acetaminophen-induced liver injury by targeting VDAC1 for degradation.
Zhu Y; Lei L; Wang X; Chen L; Li W; Li J; Zhao C; Du X; Song Y; Gao W; Liu G; Li X
Acta Pharm Sin B; 2023 Apr; 13(4):1616-1630. PubMed ID: 37139424
[TBL] [Abstract][Full Text] [Related]
14. Induction of PARP7 Creates a Vulnerability for Growth Inhibition by RBN2397 in Prostate Cancer Cells.
Yang C; Wierbiłowicz K; Dworak NM; Bae SY; Tengse SB; Abianeh N; Drake JM; Abbas T; Ratan A; Wotton D; Paschal BM
Cancer Res Commun; 2023 Apr; 3(4):592-606. PubMed ID: 37077937
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
